Zydus Cadila fights counterfeit drugs with new packaging feature
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Zydus Cadila fights counterfeit drugs with new packaging feature

31 May 2021 (Last Updated May 31st, 2021 11:48)

Zydus Cadila plans to implement the new technology in its products Remdac and Virafin Inj.

Zydus Cadila fights counterfeit drugs with new packaging feature
Zydus Cadila develops a wide range of healthcare therapies including small molecule drugs and vaccines. Credit: Marco Verch Professional Photographer.

Indian pharmaceutical company Zydus Cadila has introduced new feature in its drug packaging to help fight counterfeit products.

The company has integrated a new IT-enabled scratch code created by Hyperlink Infosystem.

It will be printed under a concealed scratchable surface, which will help customers verify products by entering the code on the pack.

Zydus Verify App connects the code and provides the brand name to authenticate the product. The app is available in both Google Play store and Apple Store.

Zydus Cadila initially plans to implement the technology in its products Remdac (Remdesivir) and Virafin Inj (Pegylated Interpheron Alpha 2b).

Products packs equipped with the new technology will be available starting third week of next month. The company also aims to implement the feature on its other products.

Cadila Healthcare (also known as Zydus Cadila) managing director Dr Sharvil Patel said: “The problem of counterfeit drugs undermines the painstaking efforts that are put in to ensure that the end user or patients receive a product that is safe and manufactured with the highest standards of quality excellence.

“Counterfeit drugs can be harmful as they may not have the desired outcome and could also be life threatening in some cases. To curb this menace we looked at a user friendly solution which can reassure the patient that the product is genuine and safe. Zydus Verify is a Tec enabled solution that will safeguard patients against counterfeit drugs.”

Zydus Cadila specialises in developing and marketing a wide range of healthcare therapies, including small molecule drugs, biologic therapeutics and vaccines.